Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Commenting on the Champions Initiative, Cradle co-founder and chief executive Stef van Grieken said that technological ...

The higher he climbs, the less he thinks about daily life, says Novo Nordisk’s Cem Ozenc. There’s no time when the mental and ...

European Opportunities Trust invests in European companies offering capital growth and is managed by Devon Equity Management Ltd. The company said net asset value per share fell 8.6% to 921.66 pence ...

EU mid-market update: Trump adds Middle East tensions to macro picture as trade war keeps volatility high; Novo Nordisk rises ...

Germany's service activity growth hits six-month high. France (CAC:IND) -0.27% France service activity falls in January. Industrial production fell 0.4% M/M in December. Iceland’s Central Bank cut its ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

In today’s news, Australian steel and aluminium could be hit after the US announced a tariff on metal imports, the real reason Donald Trump is quickly imposing tariffs, and markets are starting to ask ...

In Canada, investors are getting results from Suncor Energy Inc. and Great-West Lifeco Inc. On Wall Street, markets are ...

The president has recently hit out the EU, accusing the 27-member bloc of having "taken advantage" of the U.S. through a ...